Konferenzen  >  Medizin & Gesundheitswesen  >  Onkologie

Cancers are characterized by a high metabolic heterogeneity allowing cancer cells to survive and proliferate under microenvironment- and therapy-induced stress conditions. Recent technical developments have revealed the spatially- and temporally-resolved complexity of the metabolic networks within tumors and its role in tumor initiation and progression. The 11th ISCaM meeting, in Brussels (Belgium), will gather renowned experts in the cancer metabolism field to discuss the most recent knowledge related to metabolic alterations in cancer, and how this can be translated to the clinics to treat cancer patients.

Immunometabolism, Lipid metabolism and ferroptosis, Metabolism and therapy resistance, Tumor microenvironment and disease progression, Epigenetics, circadian clock and cancer metabolism, Tumor acidosis and imaging

Cancer Care Parcel

Tel.: [02087207418];     Email: events@cancercareparcel.com

Binaytara Foundation

This CME-accredited oncology conference, BTF's 2024 Updates on Hematology and Oncology, Fresno, is designed to improve the care of cancer patients by educating clinicians involved in cancer care. The expert faculty will present a comprehensive overview of recent updates in hematology and oncology, and practice-changing abstracts from the 2024 American Society of Clinical Oncology Annual Meeting (ASCO2024) held in June 2024. The program will feature in-depth discussions and analyses of the latest scientific discoveries and advancements. Faculty will contextualize these findings within clinical practice and explore their potential to alter current standards of care. This conference is designed for physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals, providing them with the latest updates in the field. Emphasizing a multidisciplinary approach, it will showcase the integration of new advancements into patient-centered care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Hematology, Oncology

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

CHI

In the past 11 years, CHI’s Immuno-Oncology Summit has grown to be the premier annual meeting for advancing biotherapeutics. This summit offers a comprehensive 3-day 6-track program, exploring bi- and multispecific biotherapeutics; highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, and cell-based immunotherapies; and addressing the challenges of overcoming tumor resistance. Attendees delve into predictive models, tumor microenvironment modulation, and the increasing role of AI and machine learning in cancer immunology. The summit serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology. Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives. We look forward to seeing you in Philadelphia this August 7th-9th, where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.

Tel.: [781.972.5400];     Email: chi@healthtech.com

In the past 11 years, CHI's Immuno-Oncology Summit has grown to be the premier annual meeting for advancing biotherapeutics. This summit offers a comprehensive 3-day 6-track program, exploring bi- and multispecific biotherapeutics; highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, and cell-based immunotherapies; and addressing the challenges of overcoming tumor resistance. Attendees delve into predictive models, tumor microenvironment modulation, and the increasing role of AI and machine learning in cancer immunology. The summit serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology. Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives. We look forward to seeing you in Philadelphia this August 7th-9th, where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.

Binaytara Foundation

The Southwest Hematology Oncology Conference: Precision Guided Therapy is a 1-day educational and scientific meeting that will focus on the updates in the biomarker-guided management of patients with common malignancies. This conference will feature experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. In addition, expert faculty will place key abstract findings from the 2024 ASCO Annual Meeting into a clinical context and discuss how the results may change the current standards of care. The goals of this conference are to review and critically assess practice-changing results of practice-changing clinical data and expert recommendations to incorporate biomarker-guided therapy in the management of patients with cancer.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Hematology, Oncology, Precision Guided Therapy, Malignancies

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Binaytara Foundation

This CME-accredited activity, “2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility” features leading experts who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care. The faculty will discuss barriers to using cellular therapy and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Cellular Therapy, Oncology, Hematology, Accessibility, Lymphoma, Myeloma, Acute Leukemia

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Binaytara Foundation

This CME-accredited activity, Wisconsin Multiple Myeloma & Lymphoma Summit, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Hematology, Oncology, Myeloma, Lymphoma

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

European Molecular Biology Organization – EMBO

CHI

The Next Generation Dx Summit, taking place at the Capital Hilton in Washington, D.C., on August 19-21, 2024, is the must-attend event for diagnostics advancements, as well as the nexus for international thought leaders to discuss diagnostic and technology innovation. This year’s event provides a valuable window on the state-of-the-art forecasting and future trends in point-of-care and decentralized testing, infectious disease, liquid biopsy, multi-cancer early detection, reimbursement, regulation, and companion diagnostics to improve the standard of care in medicine. This must-attend Summit offers incomparable networking and complete coverage of the most timely and important topics for the industry.

Tel.: [781.972.5400];     Email: chi@healthtech.com

Fields Institute

This workshop aims to showcase the state-of-the-art mathematical and computational models that are in use in mathematical oncology, with a particular focus on the fourteen hallmarks of cancer. New modeling challenges arise from these hallmarks. Some of the hallmarks relate to the characteristics of the cancer cells themselves (sub-cellular and cellular level), while others include more global effects such as blood circulation, the immune response, the effect and role of the microenvironment, mechanical forces, and the microbiome. Matching the biological diversity of the cancer hallmarks, is the diversity of mathematical approaches and techniques that have been used and are in use to give insight into the growth and spread of cancer – for example, continuum and discrete models; ordinary and partial differential equation models; individual-based and agent-based models; hybrid models; deterministic and stochastic approaches; analytical and computational approaches. Many of these processes act on very different spatial and temporal scales. Hence a new integrated multiscale mathematical modeling framework is needed to include new aspects and insights, such as spatial stochastic models and local and non-local partial differential equation models.

Simulation,    Systembiologie und mathematische Biologie

European Society for Translational Medicine

The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 11th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2024) held in virtual format during 6-8 September, 2024. The Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care. EUSTM-2024 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.

Tel.: [+43 1 8923 562];     Email: immuno-2024@eutranslationalmedicine.org

solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, vaccines biological research, diagnostics, biomarkers, clinical care, Immunology, MIcrobiology, life sciences, Molecular Biology, Cancer, Blood Cancers, Breast cancer, Lungs Cancer, Ovarian cancer, GIT cancer, Brain cancer, Genitourinary cancer, prostate cancer, bladder cancer,

Immunologie und Allergie,    Medizin (allgem.), Innere Medizin

Jožef Stefan Institute

As in previous editions of the conference, the ICPM will bring together professionals from the fields of plasma, medicine, biology and biochemistry in order to develop a common language, to better define key challenges and open questions and to move toward effective solutions. This time it will be organized jointly with IWPCT covering plasma for cancer therapy on Monday, Sep. 9th. Prior to the conference, the traditional Summer School will take place, starting on the weekend, Sunday, Sep. 8th, and going through mornings from Monday, Sep. 9th to Wednesday, Sep. 11th. Registrations for the summer school will be conducted separately from the registrations for the conference.

Email: icpm10@ijs.si

plasma, medicine, cancer treatment,

Plasmaphysik, Kernfusion,    Medizin (allgem.), Innere Medizin

European Helicobacter and Microbiota Study Group

The European Helicobacter and Microbiota Study Group (EHMSG) is a multidisciplinary group composed of representatives from most countries of the EU. It was founded in 1987 by a collaboration of pioneers in the field of Helicobacter and expanded its remit in 2016 to embrace the collective gastrointestinal microbiota. This includes dissemination of medical, scientific and technical information in order to promote health and decrease the burden of digestive diseases.

Each year, EHMSG hosts a conference consisting of a one-day postgraduate course followed by a 2-day workshop.

Event Secretariat;     Tel.: [+431405138318];     Email: workshop@ehmsg.org

Helicobacter, Microbiota, IBD, FMT

Gastroenterologie,    Medizin (allgem.), Innere Medizin

Fields Institute

This workshop aims to take a closer look at how mathematical and computational models can help answer clinically relevant questions and enhance multimodal treatments. Currently, a wide range of modelling approaches study cancer and have a crucial role in treatment delivery from answering questions related to cancer biology and treatment efficacy to directly helping with treatment delivery. In this workshop, we would like to bring together clinicians, biomedical experts, experimentalists, and mathematicians to explore some of the relevant questions on multimodal treatment modelling, efficacy, optimization, drug resistance and clinical delivery.

Simulation,    Systembiologie und mathematische Biologie

European Society of Oncologic Imaging

The ESOI Touchdown 2024 event is an annual meeting organized by the European Society of Oncologic Imaging, where participants can follow various lectures by leading scholars and practitioners on oncologic imaging.

ESOI Office;     Email: office@esoi-society.org

radiology, oncologic imaging, oncology

Binaytara Foundation

The “BTF Northwest Women’s Cancer Conference” is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This women's cancer conference will augment healthcare providers’ foundation of knowledge and clinical competence in the management of women’s cancers.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Breast Cancer, Gynecologic Malignancies, Oncology

Fortbildung für Gesundheitsfachberufe (CME),    Gynäkologie/Geburtshilfe

Binaytara Foundation

This CME-accredited activity Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice features leading experts in hematologic malignancies and cellular therapies who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Cellular Therapy, Oncology, Hematology, Lymphoma, Myeloma, Acute Leukemia

Fortbildung für Gesundheitsfachberufe (CME),    Hämatologie

The European Association for Cancer Research (EACR)

This conference will explore a breadth of new technical approaches to the identification and development of novel cancer therapeutics, including agents in early clinical development. The aim is to provide an accessible insight into recent developments in this rapidly evolving field, that aims to harness our insights from cancer research for the benefit of patients. The target audience for this conference is: scientists in academia and industry who are interested in the most recent developments in cancer therapeutic discovery, including small molecule, degrader, peptide, and antibody technologies. The conference will include several novel antitumour approaches in early clinical development. Join us online on 24 and 25 September to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 29 July and register before 09 September to secure your place.

Conference Officer: Hannah Barrs;     Tel.: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, therapeutic targets, cancer drug discovery, drug discovery approaches, new technical approaches to cancer therapeutics, early clinical development, small molecule technology, phenotypic screens, covalent fragment screens, degrader technology, PROTAC, molecular glue, peptide technology, oral cyclic peptide inhibitors, antibody technology, antitumour approaches, antibody drug conjugates, targeting RAS, targeting mutant p53.

kenes exhibitions

The RNA Therapeutics Symposium aims to harness the transformative potential of RNA technology for a broader spectrum of cancer therapeutics. Bringing together a diverse array of experts, including RNA biologists, systems analysts, immunologists, and drug development specialists, this event fosters a collaborative environment. It facilitates the exchange of cutting-edge research, the development of a unified scientific lexicon, and the acceleration of research and development efforts in RNA therapeutics.

Tel.: [+972 74 745 7435];     Email: skrein@kenes-exhibitions.com

RNA Therapeutics RNA Vaccines  RNA medicines RNA Manufacturing RNA technologies immunology Biotech Cancer

Conventus Congressmanagement & Marketing GmbH

Conventus Congressmanagement & GmbH;     Email: conferencemarketing@conventus.de

Binaytara Foundation

This CME-accredited activity, Park City Lymphoma Myeloma Conference, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Oncology, Hematology, Lymphoma, Myeloma, Waldenström Macroglobulinemia

Hämatologie,    Fortbildung für Gesundheitsfachberufe (CME)

Fields Institute

This workshop explores research in methods aimed at connecting mathematical models of cancer evolution and clinical data. It focuses on ecology and evolution of cancer. Traditionally, ecology and evolution have been the most “mathematical” (and perhaps the first mathematical) areas of biology. Mathematical contributions to these fields made in the 20th century are now fundamental parts of scientific knowledge. More recently, methods of ecology and evolution have found their way into oncology, bridging traditional molecular biology and mathematics including stochastic processes, dynamical systems, and nonlinear partial differential equations. New biological challenges lead to difficult mathematical problems and beautiful solutions, which are both innovative mathematically and impactful from the point of view of public health. These will be the focus of the proposed workshop .

Simulation,    Systembiologie und mathematische Biologie

Binaytara Foundation

The 4th Binaytara Precision Oncology Summit is a 2-day CME-accredited conference that offers an unparalleled opportunity for oncology professionals to delve into the latest advancements, innovations, and practices in precision oncology. The theme for this year's summit, "Current Standards and Emerging Therapies," highlights the conference's commitment to providing a comprehensive overview of the field, including in-depth discussions on the latest developments in precision oncology, alongside a thorough examination of established treatment protocols. Focus on actionable mutations ensures that the presented information translates directly into improved patient care. The summit features didactics, panel discussions, interactive case studies, and scientific abstract presentations.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

cancer, oncology, CME, continuing medical education

The European Association for Cancer Research

This conference will gather top experts in the field of cancer metabolism to discuss the metabolic alterations in tumours and how we can exploit this to treat cancer. Topics to be covered include: metabolic reprogramming in cancer beyond anabolism, metabolic transformation in cancer cells, metabolic signalling in cancer, metabolic cross-talk in the tumour microenvironment, metabolic regulation of gene expression, immune cell metabolism in cancer, nucleotide metabolism and cancer, metabolic approaches to cancer therapy, and systemic metabolic changes and their effects on cancer progression. The target audience for this conference is basic and translational scientists and clinicians, both senior and young investigators that want to have a broad and detailed overview of the most recent advances in the field of cancer metabolism.

Conference Officer: Chris Iliffe;     Tel.: [N/A];     Email: christopher.iliffe@eacr.org

cancer metabolism, adaptations of cancer, tumour biology, tumour vulnerabilities, cancer cell biology, stromal cell biology, metabolic cell wiring, cell anabolism, molecular properties of cancer cells, cancer genomics, cancer cell signalling, nutrient signalling, cancer metabolic alterations, metabolic cross-talk, the tumour microenvironment, the tumour macroenvironment, gene expression, immune cell metabolism, metabolic approaches to cancer therapy, cancer progression, cancer research, oncology

Fields Institute

Immunotherapies have revolutionized treatments for several types of cancers, but have been met with clinical trial failures in others. The idea of eliciting an immune response against a tumour is old, but we are only just beginning to harness the potential of the immune system to treat both solid and liquid tumours. To improve immunotherapeutic approaches requires understanding how the immune system interacts around and within a tumour, allowing us to establish effective immunotherapeutic protocols. Mathematical modelling can help identify the mechanisms at the heart of immunotherapeutic efficacy and design successful therapeutic regimens. Close collaboration between experimentalists, clinicians, and quantitative researchers in academia and industry is required to forward models for implementation. This workshop will focus on tightening the links between researchers in different fields to fuel immunotherapy success.

Simulation,    Systembiologie und mathematische Biologie

As usual, the annual EANO meeting will kick off with an Educational Day on Thursday, October 17 and the main programme will commence on Friday, October 18. The congress encourages exchange and collaboration between all relevant disciplines: Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology and Radiation Oncology as well as Nursing and other Allied Health Professionals, and aims to bring together scientific and clinical expertise and research to bridge gaps in our understanding and management of central nervous system tumours. EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis, and treatment of tumours of the central nervous system. The successful 2023 EANO meeting in Rotterdam attracted more than 1000 participants from all continents and was very highly rated!

Binaytara Foundation

This accredited continuing education activity, the Santa Fe Precision Oncology Symposium, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.

Tel.: [425-616-0572];     Email: cme@binayfoundation.org

Oncology, Precision Oncology, Hematology, Malignancies, Continuing Medical Education (CME)

Coalesce Research Group

We are glad to announce the 4thEuropean Congress on Cancer and Oncology Research on October 28-29, 2024 at Rome, Italy with the theme “Breaking Barriers: Collaborative Approaches in Cancer Research”. Our Aim is to bring global scientists/ researchers and business professionals to one platform. Oncology Research 2024 includes the series of B2B & B2C meetings, Oral Talks, Poster Presentations, and Workshops & Exhibitions by Industries, Academicians, Professors, and Young Forum Researchers & Students.by providing collaboration spaces and break-out rooms with tea and lunch for speakers, and delegates between sessions with invaluable networking time for you.

Tel.: [1-718-543-9362];     Email: sarahlivingstone178@gmail.com

Cells and Cell Structure Cancer Systems Biology Sarcoma Colorectal Cancer Breast-cancer Blood cancer Skin cancer Gynecologic Cancer Head and Neck Cancer Genetic Cancer Nanotechnology in cancer Organ Specific Cancer Pediatric Oncology Medical Oncology Radiation Oncology Neuro Oncology Tissue regeneration and Oncology Cancer Epidemiology Cancer Treatment & Therapy Covid & Its impact on cancer Cancer Immunotherapies Cancer Biomarkers Cancer Metastasis Cancer drugs Market Tumor Virology and Immunology Radiology and Medical Imaging Cancer Chemotherapy and Pharmacology

Binaytara Foundation

This CME-accredited activity, the 2024 Seattle Lung Cancer Conference, brings together leaders in the field of thoracic oncology to provide an extensive overview of both current and emerging strategies for managing lung cancer (NSCLC and SCLC). The primary aim of this conference is to enhance the knowledge and competence of participants, enabling them to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for lung cancer patients. The program includes detailed discussions and analyses of the latest scientific discoveries and advancements in molecular testing and targeted therapies for thoracic oncology. The expert faculty will focus on the clinical application of diagnostics, biomarkers, and various therapeutic agents, discussing how these tests and treatments can be effectively used to improve patient care.

Tel.: [425-616-0572];     Email: hanna.k@binayfoundation.org

Lung Cancer, Oncology, NSCLC, SCLC, CME, Continuing Medical Education

Spandidos Publications

ISMM28 will focus on the latest research findings and cutting-edge technologies in the field of molecular medicine, with leading experts and scholars gathering from all over the world. ISMM28 creates a broad academic platform where participants will have the opportunity to share their research results, exchange academic views, and discuss the future direction of molecular medicine.

Organizing Committee;     Tel.: [+86-15361286025];     Email: jiangjie@yujiab.com

Molecular medicine, oncology, SCI, academic conferences

Medizinisches Zentrallabor – Abteilung Transfusionsmedizin und Klinische Hämostaseologie, Klinik für Hämatologie, Zelltherapie und Hämostaseologie Bereich Hämostaseologie, MVZ Labor Dr. Reising-Ackermann und Kollegen

event lab. GmbH;     Tel.: [0341 30 88 84 62];     Email: asauerland@eventlab.org

Hämatologie,    Gefäßmedizin, Angiologie

Fraunhofer Institute for Cell Therapy and Immunology, University Hospital Leipzig

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Hospital Leipzig.

Fraunhofer Institute for Cell Therapy and Immunology, Jens Augustin;     Email: info@lion-conference.com

oncology, immunotherapy, gene therapy, cell therapy

Immunologie und Allergie,    Stammzellforschung und -therapie

Fraunhofer Institute for Cell Therapy and Immunology; Leipzig University Cancer Center (UCCL)

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.

Conference office: event lab. GmbH;     Tel.: [+49 341 30 8884-72];     Email: info@lion-conference.com

cancer immuno therapy, immune oncolocgy

The European Association for Cancer Research

Our popular Liquid Biopsies series returns for its fourth edition to bring together a slate of recognised experts who will explore how complex multi-modal liquid biopsy assays could be taken from the laboratory into clinical practice. Topics to be covered include the implementation of liquid biopsy in clinical trials, the various applications for CTCs, the basic biology of biomarker discovery, new techniques enhancing liquid biopsy, the integration of multiple blood-based analytes for multi-modal biomarkers, and how artificial intelligence can be applied to the field. This conference is suitable for a wide audience including translational scientists, researchers working in genetics, biology, molecular pathology, bioengineering, and data science, as well as clinical and non-clinical trainees, primary care physicians, radiologists, patient advocates, and colleagues from industry working in biotechnology, diagnostics, and pharmaceuticals.

Conference Officer: Hannah Barrs;     Tel.: [N/A];     Email: hannah.barrs@eacr.org

liquid biopsy, cancer research, oncology, translational research, clinical trials, clinical practice, early detection of cancer, cancer screening techniques, multi-modal assays, treatment efficacy vs resistance, treatment toxicity, cell-free DNA, cfRNA, CTCs, extracellular vesicles, extracellular proteins, blood-based analytes, AI in cancer detection and screening

The European Association for Cancer Research (EACR)

This conference aims to illuminate the intricate dynamics between ageing and cancer, fostering interdisciplinary dialogue among researchers and clinicians. By understanding the biological dimensions of cancer in ageing populations, we aspire to drive innovations in prevention, diagnosis, and treatment strategies. Ultimately, the conference seeks to catalyse collaborative efforts to confront the unique challenges posed by cancer in the ageing world, with the overarching goal of improving the quality of life and outcomes for elderly cancer patients. This conference is relevant for a diverse range of researchers, clinicians, and industry professionals. We look forward to being joined by: scientists and academics working in oncology, gerontology, genetics, and related disciplines; clinical oncologists, geriatricians, and other healthcare professionals who play a crucial role in diagnosing, treating, and supporting elderly patients with cancer; and representatives from pharmaceutical companies and biotechnology firms which develop innovative therapies and technologies to combat cancer in ageing populations. Join us online on 03 and 04 December to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 14 October and register before 11 November to secure your place.

Conference Officer: Chris Iliffe;     Tel.: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, ageing, ageing hallmarks, senescence, immunosenescence, inflammaging, aged tumour microenvironment, cancer prevention, cancer diagnosis, cancer treatment, elderly patients, treatment advances

ESMO - European Society for Medical Oncology

ESMO Asia is an annual congress specifically focused on multidisciplinary oncology in the Asian region. ESMO Asia 2024 will feature scientific sessions covering a wide range of topics related to oncology, including advances in cancer research, new treatment modalities, and discussions on the management of specific types of cancer. Its educational sessions will provide in-depth training and insights into specific aspects of oncology, ensuring that participants gain practical knowledge that they can apply in their daily practice.

ESMO Asia 2024 Secretariat;     Email: asiacongress@esmo.org

oncology, translational research, clinical trials, breast cancer, CNS, precision medicine, gastrointestinal tumours, genitourinary tumours, gynecological tumours, haemathological malignancies, head and neck cancers, immunotherapy, melanoma, sarcoma, rare tumours, thoracic cancer, supportive care, palliative care, Clinical Practice Guidelines, radiology

Translationale Medizin, Klinische Studien,    Fortbildung für Gesundheitsfachberufe (CME)

The European Association for Cancer Research (EACR), in conjunction withAstraZeneca

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, circulating tumour DNA, cell-free DNA, liquid biopsy, early cancer detection, clinical trial design, breast cancer, lung cancer, colorectal cancer, bladder cancer, virtual cancer research conference

The European Association for Cancer Research (EACR)

This meeting will delve into the profound consequences cancer can have on the body’s usual functions, and the underlying mechanisms behind these systemic effects. The ultimate goal is to explore how we might manipulate these mechanisms to develop more effective cancer treatments and improve the quality of life of patients with advanced cancer. We’ll be covering a wide range of topics including alterations in peripheral tissue function and the metabolic and inflammatory changes they induce, immune system performance, and cancer cachexia. This conference will be relevant for anyone with an interest in cancer biology, inter-organ communication, the role of cytokines, chemokines, and hormones in cancer, as well as cancer-induced changes in behaviour and metabolism.

Join us online on 25 and 26 February to learn more about this fascinating topic! Submit your abstract before 13 January and register before 03 February to secure your place.

Conference Officer: Hannah Barrs;     Tel.: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, cancer biology, immunology, cancer cachexia, inter-organ communication, liver function, muscle function, adipose tissue function, tissue function, metabolic changes, inflammatory changes, tumour metastasis, novel therapeutic interventions, cytokines, chemokines, hormones, cancer metabolism

Biologie,    Immunologie und Allergie

Infonet

4th International Cancer Expo and Conference welcomes you as our guest to the City of Philadelphia, USA during March 06- 08, 2025. iCancer Conference 2025 has a theme "Innovations in Cancer Research".

Tel.: [06172752612];     Email: jessie@icancerconference.org

Keywords: Conference, Cancer, oncology, Oncology - Medical, oncology meetings, Cancer Conference, Philadelphia, Breast cancer conference Cancer genes, Chemotherapy, Hypoxia, Sarcomas, Lung Cancer, Oral Cancer, Bladder Cancer, Skin Cancer, Hematology, Medical Imaging, Prognosis, Radiotherapy, clinical trials, Epidemiology, Breast cancer, Cancer, Geneticist, Immune system, Pathologist, Prosthesis, Thermography, X-ray, Biopsy,

The European Association for Cancer Research (EACR)

One of our most popular conferences, Defence is the Best Attack 2025 will be our fifth edition on this topic. Participants will learn about the most recent advances in the field of immunotherapy from the basic science to clinical studies, including the identification of novel targets. You will gain an improved understanding of the mechanisms of action of therapeutic interventions, and benefit from discussions about biomarkers of response to treatment and mechanisms of intrinsic and acquired resistance to immunotherapy.

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, immunotherapy, immune-oncology, molecular oncology, tumour-immune system interactions, novel therapeutic approaches, basic cancer research, clinical cancer research, treatment response biomarkers, intrinsic treatment resistance mechanisms, acquired treatment resistance mechanisms, immune checkpoints, microbioma, vaccines, immune cell therapies.

Fusion

Laura Trundle, Director;     Email: laura@fusion-conferences.com

DNA Damage Response, cancer biology, replication stress, cancer therapies, PARP inhibitors, BRCA, clinical development

Molekularbiologie,    Genomforschung und Bioinformatik